09/07/2024 - uniQure NV: uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

The text version of this document is not available. You can access the original document here.

Attachments

• Original Link
• Permalink

Disclaimer

uniQure NV published this content on 09 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 July 2024 21:39:12 UTC.